Dr. Roopa Reddy, MD

Dr. Reddy practices at San Pedro Surgery Center, Inc. in San Pedro, California.

Dr. Reddy's NPI, 1821007709, was assigned on August 7, 2006. Dr. Reddy graduated from Wayne State University School of Medicine in 1989. Dr. Reddy holds California license G73759.

Dr. Reddy's primary practice is San Pedro Surgery Center, Inc., at 1360 W 6th St, San Pedro, CA 90732 in Los Angeles County. The practice phone is (888) 819-1010.

Dr. Reddy's primary practice is San Pedro Surgery Center, Inc. in San Pedro, California. Dr. Reddy is also affiliated with Providence Little Company of Mary Medical Center San Pedro. The medical group on file is Torrance Memorial Physician Network. Dmand AI also links Dr. Reddy to 3 more hospitals, 3 home health agencies, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reddy practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Reddy's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Reddy is licensed in California.

CMS data shows 2,039 Medicare services from Dr. Reddy across 12 procedure codes in 2024, for 384 Medicare patients. Medicare paid $179,644 for them. Every service was in an office.

CMS counts 384 Medicare patients who saw Dr. Reddy in 2024. The largest group is 65 to 74, with 146 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Reddy's median patient age at 72, with 72% women.

In 2024, Dr. Reddy wrote 5,329 Medicare Part D claims for 333 patients. 84% of them were for generic drugs. CMS names the drug for 4,636 of them, across 96 drugs with 11 or more claims each, at $550,122 in total drug cost. In 2023, CMS named 5,026 claims across 98 drugs.

Dr. Reddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reddy as offering telehealth.

Dmand AI links 16 papers to Dr. Reddy, published from 2015 to 2024. 2015 was the busiest year, with 2. The most frequent topics are Biocompatible Materials, Anti-Bacterial Agents and Bombyx. Dr. Reddy has published most often in J Oral Maxillofac Pathol.

CMS Open Payments shows 834 general payments to Dr. Reddy from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $2,295.

Dr. Reddy graduated from Wayne State University School of Medicine in 1989.